Menarini Group Company to Speak at ACCESS CHINA BD Forum @ BIO

June 15, 2025 (Boston) — We are glad to announce that Victoria Balannik, the Head of Global External Innovation and BD&L of Stemline Therapeutics Inc, a Menarini Group Company, will be presenting at the ACCESS CHINA BD Forum @BIO on June 15, 2025. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.

About Stemline Therapeutics Inc, a Menarini Group Company

The Menarini Group, established in 1886 and headquartered in Florence, Italy, is a multinational pharmaceutical company with a presence in over 140 countries and more than 17,000 employees. Menarini operates across a broad range of therapeutic areas, including oncology, cardiology, gastroenterology, infectious diseases, and pain management. In 2020, the company expanded its oncology footprint through the acquisition of U.S.-based Stemline Therapeutics and is currently advancing a pipeline of first- and best-in-class therapies for hard-to-treat malignancies. The Menarini Group is committed to innovation, quality, and strategic global partnerships to improve patient care worldwide.

About the speaker

Victoria Balannik is Head of Global External Innovation and BD&L at Menarini Stemline, where she leads strategic business development efforts focused on oncology. Victoria comes with deep expertise in pharma innovation, sourcing and executing licensing deals, and driving partnerships across global markets. Victoria combines a strong scientific foundation with a disciplined, finance-oriented approach to deal-making. She brings prior experience as a healthcare investor, where she focused on company creation and early-stage pharma investments.

About ACCESS CHINA BD Forum @BIO

‘ACCESS CHINA BD Forum @BIO is scheduled to be held on June 15, 2025, at Seaport Boston Hotel. This year’s ACCESS CHINA BD Forum @BIO will convene 80 distinguished guests for an afternoon of strategic networking, business development, and thought leadership, with a special emphasis on China’s dynamic biotechnology landscape and global collaboration opportunities.

Conference Name: ACCESS CHINA BD Forum @BIO

Date: June 15, 2025

Content: Keynote Speeches, Panel Discussion, 10 Elevator Pitch, and Closed-Door Dinner Reception.

Participants: Pharma/Biotech senior management and BD’s

View more information at https://biotochina.org/